Prevalence of Chronic Obstructive Pulmonary Disease in Adults Aged 40 Years and Older in China From 2014 to 2024: A Systematic Review and Meta-Analysis
Restricted accessReview articleFirst published online July, 2025
Prevalence of Chronic Obstructive Pulmonary Disease in Adults Aged 40 Years and Older in China From 2014 to 2024: A Systematic Review and Meta-Analysis
Chronic Obstructive Pulmonary Disease (COPD) imposes a heavy disease burden on China. The aim of this study was to identify the prevalence of COPD in adults aged 40 years and older in China through a systematic review and meta-analysis. A web-based search of 11 databases (including PubMed and Web of Science) from January 2014 to September 2024, using specified search/MeSH (Medical Subject Headings) terms and keywords, was conducted. A total of 92 studies (39 320 patients) were included. The combined prevalence of COPD in Chinese adults aged 40 years and older from 2014 to 2024 was 12.1%. Subgroup analysis showed that the prevalence was higher in males 16.4% than in females 8.4%. The lowest prevalence was 4.8% in the age group of 40 to 49 years and 23.7% in the age group of over 70 years. The prevalence was highest in patients with a BMI of less than 18.5 kg/m2 (22.4%) and decreased with increasing BMI. The prevalence was highest in Northwestern China (13.9%) and lowest in Southern China (9.2%), and was higher in rural residents (13.7%) than urban residents (11.1%). The prevalence was higher among current smokers (18.7%) and former smokers (18.7%) than among non-smokers (7.9%).
CelliBFabbriLCrinerG, et alDefinition and nomenclature of chronic obstructive pulmonary disease time for its revision. Am J Respir Crit Care Med. 2022;206(11):1317-1325. doi:10.1164/rccm.202204-0671PP
HuWFangLZhangHNiRPanG.Global disease burden of COPD from 1990 to 2019 and prediction of future disease burden trend in China. Public Health. 2022;208:89-97. doi:10.1016/j.puhe.2022.04.015
4.
YinPWuJWangL, et alThe Burden of COPD in China and its provinces: findings from the global burden of disease study 2019. Front Public Health. 2022;10:859499. doi:10.3389/fpubh.2022.859499
5.
ParkJEZhangLHoYF, et alModeling the health and economic burden of chronic obstructive pulmonary disease in china from 2020 to 2039: a simulation study. Value Health Reg Issues. 2022;32:88-16. doi:10.1016/j.vhri.2022.06.002
6.
RongJGeYHChenGMWangLDingHY.Meta-analysis of prevalence of COPD among Chinese aged 40 years old and above, 2010-2019. Modern Prev Med. 2020;47(13):2305-23092336.
7.
QuanZYanGWangZ, et alCurrent status and preventive strategies of chronic obstructive pulmonary disease in China: a literature review. J Thorac Dis. 2021;13(6):3865-3877. doi:10.21037/jtd-20-2051
8.
FangLGaoPBaoH, et alChronic obstructive pulmonary disease in China: a nationwide prevalence study. Lancet Respir Med. 2018;6(6):421-430. doi:10.1016/s2213-2600(18)30103-6
9.
MoherDLiberatiATetzlaffJAltmanDGGrpP.Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (reprinted from annals of internal medicine). Phys Ther. 2009;89(9):873-880. doi:10.1093/ptj/89.9.873
10.
VestboJHurdSSAgustiAG, et alGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347-365. doi:10.1164/rccm.201204-0596PP
11.
ZengXZhangYKwongJS, et alThe methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med. 2015;8(1):2-10. doi:10.1111/jebm.12141
12.
JiangTF.Investigation and analysis of the incidence of chronic obstructive pulmonary disease in Bishan District, Chongqing. J Youjiang Med Univ. 2015;37(06):834-838. doi:10.369/j.issn.1001-5817.2015.06.026 (In Chinese)
13.
JiangTFDingF.Logistic analysis of risk factors of chronic obstructive pulmonary disease in people over 40 years old in Bishan District. J Youjiang Med Univ. 2015;37(05):727-731. doi:10.3969/j.issn.1001-5817.2015.05.025 (In Chinese)
14.
GuY.Research of Incidence and Under-Diagnosis of COPD in 40-Year-Old Population in a Community of Beijing. Xinxiang Medical College; 2016. (In Chinese)
15.
ChenXLIDXDingJ.Prevalence rate and risk factors of chronic obstructive pulmonary disease in Xicheng District of Beijing. Chin Gen Pract. 2016;19(36):4461-4467. doi:10.3969/j.issn.1007-9572.2016.36.012 (In Chinese)
16.
WangLDZhouJDuXQLuFFCuiDY.Prevalence of chronic obstructive pulmonary disease in urban and rural residents in Changzhou. Chin J Gen Prac. 2016;14(06):984-989. doi:10.16766/j.cnki.issn.1674-4152.2016.06.033 (In Chinese)
17.
YangHFChenSZZhengPLIWW. An investigation on the prevalence of chronic obstructive pulmonary disease and its influencing factors among residents in Yongjia County. J Prev Med. 2016;28(06):570-573. doi:10.19485/j.cnki.issn1007-0931.2016.06.008
18.
LinFR.Investigation and suggestions on the prevalence and risk factors of chronic obstructive pulmonary disease among high-risk groups in the community. J Tradit Chin Med. 2016; 24(22):30-32. doi:10.16690/j.cnki.1007-9203.2016.22.010 (In Chinese)
19.
FanSYLuHBXiaokaitiYBLY. Analysis of prevalence and influence factor of chronic obstructive pulmonary disease in urban residents in Korla, Xinjiang. Bull Dis Control Prev. 2017;32(6):12-16. doi:10.13215/j.cnki.jbyfkztb.1709012
20.
QiaoLY.Epidemic Situation and Risk Factors Analysis of Chronic Obstructive Pulmonary Disease in Partial Areas of Inner Mongolia. Inner Mongolia Medical University; 2017. (In Chinese)
21.
ChenD.Prevalence and influence factors of COPD among urban and rural residents in 4 joint regions of Sichuan, Yunnan and Guizhou. Anhui Med Pharm J. 2017;21(03):514-518. doi:10.3969/j.issn.1009-6469.2017.03.031 (In Chinese)
22.
LvHNLiHTZhangTT, et alEpidemiological investigation of chronic obstructive pulmonary disease in urban men of Maoming City. Guangdong Med J. 2017;35(03):270-274 (In Chinese)
23.
ZhangXYMaJMengGP, et alAnalysis on prevalence of chronic obstructive pulmonary disease based on pulmonary function screening in Changchun urban area of Jilin province. J Jilin Univ Med Ed. 2017;43(05):1047-1052. doi:10.13481/j.1671-587x.20170536
24.
DongTXuXYChenXFZhouWWLIYDengY.The risk factors of chronic obstructive pulmonary disease in non-smokers of Sichuan province. J Prev Med Inform. 2018;34(05):582-585 (In Chinese).
25.
LiuX.Prevalence of Chronic Obstructive Pulmonary Disease and its Factors at National Surveillance Site of Jilin Province in 2014. Jilin University; 2018. (In Chinese)
26.
ShaoYYangYFQinMF, et alPrevalence and influencing factors of COPD among residents aged 40 and above in Yunnan Province. Modern Prev Med. 2018;45(20):3654-3658. (In Chinese)
27.
ZhouXFRuanXNLinT, et alPrevalence of COPD and its association with environmental behavior factors in Pudong New District in Shanghai. Modern Prev Med. 2018;45(22):4054-4082. (In Chinese)
28.
DingXBMDQTangWGChenTShenZZQiuJP. Prevalence of chronic obstructive pulmonary disease and its influence factors in Chongqing Municipality. J Prev Med Public Health. 2018;29(03):57-61. doi:10.3969/j.issn.1006-2483.2018.03.015 (In Chinese)
29.
HuangJHLuFYWuQSChenHZhouM.Study on the prevalence rate and related risk factors of chronic obstructive pulmonary disease in the parts of community of Wuxi city. J Clin Pulm Med. 2018;23(03):459-462. (In Chinese)
30.
LiaoPHZheWLiuLXZhangRZhangYJFuerhatiW.Analysis of the morbidity and influencing factors of chronic obstructive pulmonary disease in residents (≥ 40 years old) of Xinjiang monitoring stations. Chin J Prev Contr Chron Dis. 2018;26(08):576-579. doi:10.16386/j.cjpccd.issn.1004-6194.2018.08.004 (In Chinese)
31.
LiuPYWuHY.Investigation and analysis of chronic obstructive pulmonary disease and its risk factors among permanent residents in Hainan Province. Chin J Prev Contr Chron Dis. 2018;26(12):919-922. doi:10.16386/j.cjpccd.issn.1004-6194.2018.12.009 (In Chinese)
32.
MaBYMaFQQingY.Chronic obstructive pulmonary disease factors in Linxia area Research and prevention measures. Int J Med Sci. 2018;39(04):296-299. doi:10.3969/j.issn.1001-8883.2018.04.004 (In Chinese)
33.
ShiWWLiuYHZhangF, et alSurvey on the prevalence and risk factors of chronic obstructive pulmonary disease in the population over 40 years in parts of areas of Hebei province. Hebei Med J. 2018;40(09):1419-1422. doi:10.3969/j.issn.1002-7386.2018.09.035
34.
YiFLYiST.Epidemiological investigation and prevention measures of chronic obstructive pulmonary disease. Med J Chin PLA. 2018;36(2):171-173. doi:10.13704/j.cnki.jyyx.2018.02.004
35.
ZhangYEWuTTMaLX, et alInvestigation of the epidemic characteristics and risk factor for chronic obstructive pulmonary disease among residents from monitoring point in Ningxia. Chin J Prev Contr Chron Dis. 2018;22(03):231-234. doi:10.16462/j.cnki.zhjbkz.2018.03.005
36.
ZhangYFuCFKouYHLiJ.Prevalence rate and its impact factors of chronic obstructive pulmonary disease for residents aged above 40 years old in city of Shapingba, Chognqing. Int J Respir. 2018;38(5):352-356. doi:10.3760/cma.j.issn.1673-436X.2018.05.007 (In Chinese)
37.
WangZHeZyQiYJChenSMLuYX.Prevalence and risk factors for chronic obstructive pulmonary disease of sanitation workers over 40 years of age in Qingxiu District of Nanning City. Guangxi Med J. 2019;41(20):2614-2617. doi:10.11675/j.issn.0253-4304.2019.20.17 (In Chinese)
38.
LuoLLYuJGuoSM, et alPrevalence and influencing factors of chronic obstructive pulmonary disease among middle-aged and elderly residents in Jiangxi province. Chin J Public Health. 2019;35(11):1482-1486. doi:10.11847/zgggws1120324
39.
YanWShiQWanMJ, et alThe prevalence and influencing factors of chronic obstructive pulmonary disease among permanent residents in monitoring areas of Jiangxi Province. Chin J Prev Contr Chron Dis. 2019;27(07):507-511. doi:10.16386/j.cjpccd.issn.1004-6194.2019.07.006 (In Chinese)
40.
Gek.Epidemiological Investigation on Prevalence, Risk Factors and Mental Health Survey of COPD in Mianyang. Southwest Medical University; 2019. (In Chinese)
41.
ZhangJLiDSXuYY.Prevalence and influencing factors of chronic obstructive pulmonary disease among residents over 18 years old in Changsha City of Hunan Province. Occup Health. 2019;35(6):806-809. doi:10.13329/j.cnki.zyyjk.2019.0217
42.
Gamacangjue Ya-JieLIGuo-XiaBAI.Prevalence of chronic obstructive pulmonary disease among residents aged 40 years and above in Tibet in 2015: a cross-sectional survey. Chin J Public Health. 2019;35(1):104-106. doi:10.11847/zgggws1119365
43.
GuanYAXD. Epidemiological survey of chronic obstructive pulmonary disease among residents aged 40 and above in Xining City. S Chin J Prev Med. 2019;45(05):478-480. doi:10.13217/j.scjpm.2019.0478 (In Chinese)
44.
ShengWHuangYDengZMaH.Investigation of the prevalence and diagnosis of chronic obstructive pulmonary disease in a group of elderly individuals residing in an Island Area of Ningbo. Can Respir J. 2019;2019:6918340. doi:10.1155/2019/6918340
45.
ZhaZQLengRXXuW, et alPrevalence and risk factors of chronic obstructive pulmonary disease in Anhui Province, China: a population-based survey. BMC Pulm Med. 2019;19:102. doi:10.1186/s12890-019-0864-0
46.
ChenJYZhongWLLinXQZhangYHZhuY.Prevalence and influencing factors of chronic obstructive pulmonary disease among middle-aged and elderly population in Fujian province. Chin J Public Health. 2020;36(2):170-173. doi:10.11847/zgggws1122525
47.
HuZPWangYPLIYJ. Prevalence and risk factors of COPD in some areas of Shanxi Province. Chin J Dis Contr Prev. 2020;24(10):1233-1236. doi:10.16462/j.cnki.zhjbkz.2020.10.024
48.
XuLXuQQMuHDZhongSZhouM.Clinical characteristics and current situation of the diagnosis and treatment of chronic obstructive pulmonary disease in community population of Jinshan District in Shanghai. Shanghai Med J. 2020;43(08):454-458. doi:10.19842/j.cnki.issn.0253-9934.2020.08.002 (In Chinese)
49.
ZhaoYL.Regional Investigation Report and Comparative Analysis of Chronic Obstructive Pulmonary Disease in Yangzhou. Yangzhuo University; 2020. (In Chinese)
50.
CaoYChaiDLiuWM, et alAnalysis of the prevalence and awareness rates of chronic obstructive pulmonary disease in the elderly in Xinjiang Uygur Autonomous Region. Chin J Geriatr. 2020;39(12):1472-1476. doi:10.3760/cma.j.issn.0254-9026.2020.12.024 (In Chinese)
51.
WuMLiuQHGuoYM, et alAn epidemiological investigation of COPD in people aged 40 years or older in Fuzhou. Int J Respir. 2020;40(02):107-113. doi:10.3760/cma.j.issn.1673-436X.2020.02.005 (In Chinese)
52.
WuYLOuTTLiCMZhuangXB.Analysis of the prevalence and risk factors of chronic obstructive pulmonary disease in Quanzhou City. Chronic Pathematol J. 2020;21(11):1692-1694. doi:10.16440/j.cnki.1674-8166.2020.11.025
53.
YinLHuangYLJinDHHuLPXIZ. Prevalence and influencing factors of chronic obstructive pulmonary disease among residents (≥40 years old) in Hunan Province. Chin J Prev Contr Chron Dis. 2020;28(10):731-734. doi:10.16386/j.cjpccd.issn.1004-6194.2020.10.003 (In Chinese)
54.
ZhouWWangHLiD, et alPrevalence and risk factors of chronic obstructive pulmonary disease among community residents in Beijing. Chin J Med. 2020;55(05):500-503. doi:10.3969/j.issn.1008-1070.2020.05.011
55.
JiangHSTongXHChenJW, et alScreening methods and characteristics of chronic obstructive pulmonary disease in rural grassroots. Chin Prim Health Care. 2020;34(11):21-24. doi:10.3969.j.issn.1001-568X.2020.11.0006
56.
YanXXuLShiBWangHXuXXuG.Epidemiology and risk factors of chronic obstructive pulmonary disease in Suzhou: a population-based cross-sectional study. J Thorac Dis. 2020;12(10):5347-5356. doi:10.21037/jtd-20-1616
57.
DongTXuXYDengY, et alPrevalence and influencing factors of chronic obstructive pulmonary disease among middle-aged and elderly residents in Sichuan province, 2015. Chin J Public Health. 2021;37(12):1762-1765. doi:10.11847/zgggws1130083
58.
SuJTaoRLiuJN, et alPrevalence and influencing factors of chronic obstructive pulmonary disease among residents aged 40 and above in Jiangsu province. Chin J Public Health. 2021;37(11):1626-1630. doi:10.11847/zgggws1129731
59.
DuWY.Study on the Prevalence and Related Risk Factors of Chronic Obstructive Pulmonary Disease in Cangzhou Area. Chengde Medical College; 2021. (In Chinese)
60.
LiYL.Analysis of Prevalence and Influencing Factors of Chronic Obstructive Pulmonary Disease in Rural Areas of Gansu Province. Lanzhou University; 2021. (In Chinese)
61.
ShangGCY. Prevalence of Chronic Obstructive Pulmonary Disease and Establishment of Disease Risk Assessment Model in Liaoning Province, China. China Medical University; 2021. (In Chinese)
62.
XiaHZhouDLSunZYZhangHYaoZQZhangY.Investigation on the prevalence, diagnosis and treatment of chronic obstructive pulmonary disease among the elderly in a township of Yuyao, Zhejiang Province. Modern Prac Med. 2021;33(11):1456-1458. doi:10.3969/j.issn.1671-0800.2021.11.023 (In Chinese)
63.
HanYXWeiYQDongZ.Prevalence of chronic obstructive pulmonary disease and its awareness among residents aged 40 years and above in Beijing. Chin J Health Educ. 2021;37(02):130-134. doi:10.16168/j.cnki.issn.1002-9982.2021.02.008 (In Chinese)
64.
LiSJinWLiYYangYXuJ.Epidemiological investigation and analysis of COPD patients aged 65 and above in Liaoning Province. J Public Health Prev Med. 2021;32(04):84-87. doi:10.3969/j.issn.1006-2483.2021.04.019
65.
ShiYMWuLXiaoMYTianLChenYPWangLJ.Epidemiological investigation and risk factors analysis of chronic obstructive pulmonary disease in the population aged 40 years or older in Guiyang city. Jin J Med Univ. 2021;44(05):335-338. doi:10.3969/j.issn.1000-9760.2021.105.008 (In Chinese)
66.
WangJCYiKZengQ, et alEpidemiological survey of chronic obstructive pulmonary disease among permanent residents aged ≥ 40 years in Mianyang City and its influencing factors analysis. Shandong Med J. 2021;61(5):47-50. doi:10.3969/j.issn.1002-266X.2021.05.012
67.
WangYDLiZXuD, et alPrevalence and influencing factors of chronic obstructive pulmonary disease in rural areas of Moyu County, Xinjiang. J Third Mil Med Univ. 2021;43(22):2485-2494. doi:10.16016/j.1000-5404.202105079
68.
ZhaoCSunPPZhangEM, et alAssociation of smoking and second-hand smoking with chronic obstructive pulmonary disease among residents aged 40 years or above in 10 communities of Beijing City. Chin J Clin. 2021;15(06):450-458. doi:10.3877/cma.j.issn.1674-0785.2021.06.009
69.
ZhengJZhaoYXWangYTMaLX.Investigation on the prevalence and related risk factors of chronic obstructive pulmonary disease in Shunyi District, Beijing. J Med Inform. 2021;34(2):108-112. doi:10.3969/j.issn.1006-1959.2021.02.029
70.
ZhuXWWangXDLIK. Risk assessment and influencing factors investigation of chronic obstructive pulmonary disease among middle-aged and elderly people in Zhangjiagang City. Occup Health. 2021;37(04):499-502. doi:10.13329/j.cnki.zyyjk.2021.0128 (In Chinese)
71.
ZhangDDLiuJNYeQ, et alAssociation between socioeconomic status and chronic obstructive pulmonary disease in Jiangsu province, China: a population-based study. Chin Med J. 2021;134(13):1552-1560. doi:10.1097/cm9.0000000000001609
72.
GaoCCZhangJYChenXXZhangBYTangJLGuoXL.Prevalence and risk factors of chronic obstructive pulmonary disease among residents aged 40 years and above in Shandong Province. Modern Prev Med. 2022;49(18):3271-3282. doi:10.20043/j.cnki.MPM.202202240
73.
GaoSGaoJRYanGL.Epidemiological characteristics and risk factors of COPD in people over 60 years old in Chaohu City, Anhui Province. J Prev Med Public Health. 2022;33(1):136-140. doi:10.3969/j.issn.1006-2483.2022.01.030
74.
HuangL.Prevalence and Influencing Factors of Chronic Obstructive Pulmonary Disease Among the Residents Aged 40 or Older in Guizhou Province. Guizhou Medical University; 2022. (In Chinese)
75.
WangQ.Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease among the Residents Who Aged More Than 40 Years in YinChuan. Ningxia Medical University; 2022. (In Chinese)
76.
ZhaoXLZhangDKLuHYYangYX.Analysis of the screening results of COPD in Taizhou in 2021. Health Educ Health Promot. 2022;17(06):599-606. doi:10.16117/j.cnki.31-1974/r.202206599 (In Chinese)
77.
GengCXXuKWangJYYangH.Prevalence and influencing factors of chronic obstructive pulmonary disease among smokers aged ≥40 years in Qingdao. S China J Prev Med. 2022;48(08):943-947. (In Chinese)
78.
KongXLZhouYHZouWJQiangDRXuMRZhuHM.Prevalence and risk factors of chronic obstructive pulmonary disease among middle-aged and elderly residents in Wujin District, Changzhou City. China Health Indus. 2022;19(6):30-34. doi:10.16659/j.cnki.1672-5654.2022.06.030 (In Chinese)
79.
HuangLWangYYLiuTLiLYangJY.An analysis in the prevalence and influencing factors of COPD among people aged 40 years and above in Guizhou Province. Chin J Dis Contr Prev. 2022;26(5):529-553. doi:10.16462/j.cnki.zhjbkz.2022.05.007
80.
LiuHMQiaoLYXiYFQianYG.Prevalence and influencing factors of chronic obstructive pulmonary disease in residents (≥40 years old) of Inner Mongolia in 2019. Chin J Prev Contr Chron Dis. 2022;30(03):192-195. doi:10.16386/j.cjpccd.issn.1004-6194.2022.03.007 (In Chinese)
81.
WangHMWangXH.Prevalence and risk factors of chronic obstructive pulmonary disease in Lanzhou. Gansu Med J. 2022;41(02):130-133. doi:10.15975/j.cnki.gsyy.2022.02.020 (In Chinese)
82.
ZouBMChaiWS.Epidemiological investigation and risk factors analysis of COPD in Jinzhou. J Jinzhou Med Univ. 2022;43(03):96-100. doi:10.13847/j.cnki.lnmu.2022.03.018 (In Chinese)
83.
ChenJYinYZhangY, et alChronic obstructive pulmonary disease prevalence and associated risk factors in adults aged 40 years and older in Southeast China: a cross-sectional study during 2019-2020. Int J Chron Obstruct Pulmon Dis. 2022;17:2317-2328. doi:10.2147/copd.S377857
84.
JiLCYinJFLuCR, et alControl of chronic obstructive pulmonary disease in urban populations: findings from a cross-sectional prevalence survey in Shenzhen, China. Environ Sci Pollut Res Int. 2022;29(8):11843-11853. doi:10.1007/s11356-021-16553-z
85.
PengQZhouHY.Investigation on the disease burden and risk factors control of chronic obstructive pulmonary disease in Longhua district, Shenzhen. Chin Evi Nurs. 2023;9(07):1252-1255. doi:10.12102/j.issn.2095-8668.2023.07.020 (In Chinese)
86.
TangYMZhangLLiQ, et alVariation in prevalence and impact factors of chronic obstructive pulmonary disease among residents aged over 40 years in disease surveillance sites of Hubei province between2014 and 2019: a comparison analysis. Chin J Public Health. 2023;39(5):594-599. doi:10.11847/zgggws1138472
87.
ChenXYFangLZhaoM, et alStudy on the morbidity of chronic obstructive pulmonary disease and its influencing factors in residents (≥40 years old) of Zhejiang Province in 2019. Chin J Prev Contr Chron Dis. 2023;31(02):96-100. doi:10.16386/j.cjpccd.issn.1004-6194.2023.02.004 (In Chinese)
88.
LinAMaoCRaoB, et alDevelopment and validation of nomogram including high altitude as a risk factor for COPD: a cross-sectional study based on Gansu population. Front Public Health. 2023;11:1. doi:10.3389/fpubh.2023.1127566
89.
YinXZhengZDongY, et alComparison of newly diagnosed COPD patients and the non-COPD residents in Shanghai Minhang District. Front Public Health. 2023;11:1. doi:10.3389/fpubh.2023.1102509
90.
ZhangXLeiZWuY, et alPrevalence and risk factors for COPD in an urbanizing rural area in Western China: a cross-sectional study. Int J Chron Obstruct Pulmon Dis. 2023;18:459-468. doi:10.2147/copd.S400213
91.
JinLYanSCXuLLZhouY.Prevalence of chronic obstructive pulmonary disease of residents aged 40 years and above in Heilongjiang Province and analysis of the risk factors of COPD. Chin J Public Health Manag. 2023;39(06):905-908. doi:10.19568/j.cnki.23-1318.2023.06.0039 (In Chinese)
92.
LiSQXuJFZhengLXueMBaDJ.Prevalence and related risk factors of chronic obstructive pulmonary disease in community-dwelling elderly in Shanghai Minhang district. J Tongji Med Univ. 2023;44(06):864-871. doi:10.12289/j.issn.1008-0392.23112 (In Chinese)
93.
BaiYShiXKJiangDXWangXPXuALiDH.Epidemiological characteristics of chronic obstructive pulmonary disease and its related factors in rural areas of Pingchang County. Prac Prev Med. 2023;30(10):1239-1242. doi:10.3969/J.ISSN.1006-3110.2023.10.020 (In Chinese)
94.
FangCQ.Prevalence and Factors of Chronic Obstructive Pulmonary Disease in Zhangjiagang. Soochow University; 2023. (In Chinese)
95.
ChenLJLiuMFZhangHFChenJXLiuYHMaXY.Epidemiological data update and implications of chronic obstructive pulmonary disease for people older than 40 years in Yinchuan city. Chin J Health Manag. 2023;17(12):893-898. doi:10.3760/cma.j.cn115624-20230901-00111
96.
DongCZGuYBGuSJ.Screening and risk factors analysis of chronic obstructive pulmonary disease among residents aged ≥40 years in a township of Changshu City. South China J Prev Med. 2024;50(08):754-757. doi:10.12183/j.scjpm.2024.0754 (In Chinese)
97.
TangYMLiuSSZhangL, et alEpidemiological status and influencing factors of chronic obstructive pulmonary disease in the surveillance area of Hubei Province from 2019 to 2020. Chin Prev Med. 2024;25(08):996-1001. doi:10.16506/j.1009-6639.2024.08.007 (In Chinese)
98.
HuangLXZhangJChenLJWangBGaoPY.Epidemiological characteristics and risk factors of chronic obstructive pulmonary disease (COPD) in Gansu Province. Modern Prev Med. 2024;51(15):2726-2747. doi:10.20043/j.cnki.MPM.202404050 (In Chinese)
99.
YangYX.Analysis of Epidemiology and the Influencing Factors of Chronic Obstructive Pulmonary Disease Among Residents Aged 40 and Above in Hebei Province. Hebei University; 2024. (In Chinese)
100.
ZhangGDYanJNTongSYuLZ.Morbidity and influencing factors of chronic obstructive pulmonary disease in residents (≥40 years old) of Liaoning Province. Chin J Prev Contr Chron Dis. 2024;32(03):208-212. doi:10.16386/j.cjpccd.issn.1004-6194.2024.03.009 (In Chinese)
101.
LiYYangYFWeiR, et alAnalysis of the current status and factors affecting the prevalence of chronic obstructive pulmonary disease in Ningxia residents ≥40 years old. Chin J Prev Contr Chron Dis. 2024;32(01):59-61. doi:10.16386/j.cjpccd.issn.1004-6194.2024.01.011 (In Chinese)
102.
WenGMengJPengP, et alPrevalence of chronic obstructive pulmonary disease and its associated risk factors in Yunnan Province, China: a population based cross-sectional study. Int J Chron Obstruct Pulmon Dis. 2024;19:1531-1545. doi:10.2147/copd.S459267
103.
JarhyanPHutchinsonAKhawDPrabhakaranDMohanS.Prevalence of chronic obstructive pulmonary disease and chronic bronchitis in eight countries: a systematic review and meta-analysis. Bull WHO. 2022;100(3):216-230. doi:10.2471/blt.21.286870
104.
VarmaghaniMDehghaniMHeidariESharifiFMoghaddamSSFarzadfarF.Global prevalence of chronic obstructive pulmonary disease: systematic review and meta-analysis. East Mediterr Health J. 2019;25(1):47-57. doi:10.26719/emhj.18.014
105.
BlancoIDiegoIBuenoP, et alGeographic distribution of chronic obstructive pulmonary disease prevalence in Africa, Asia and Australasia. Int J Tuberc Lung Dis. 2019;23(10):1100. doi:10.5588/ijtld.19.0015
106.
LiuZLiYHCuiZY, et alPrevalence of tobacco dependence and associated factors in China: findings from nationwide China Health Literacy Survey during 2018-19. Lancet Reg Health West Pac. 2022;24:1. doi:10.1016/j.lanwpc.2022.100464
107.
ZhaoQQCongSFanJ, et alPrevalence of smoking in adults aged 40 years and above in China, 2019-2020. Zhonghua Liu Xing Bing Xue Za Zhi. 2023;44(5):735-742. doi:10.3760/cma.j.cn112338-20230119-00035
108.
LiJZhuLWeiY, et alAssociation between adiposity measures and COPD risk in Chinese adults. Eur Respir J. 2020;55(4):1. doi:10.1183/13993003.01899-2019
109.
KamalRSrivastavaAKKesavachandranCN.Meta-analysis approach to study the prevalence of chronic obstructive pulmonary disease among current, former and non-smokers. Toxicol Rep. 2015;2:1064-1074. doi:10.1016/j.toxrep.2015.07.013
110.
KaurMChandelJMalikJNauraAS.Particulate matter in COPD pathogenesis: an overview. Inflamm Res. 2022;71(7-8):797-815. doi:10.1007/s00011-022-01594-y
ZhengRCuiF.On the realization of tobacco control goals of healthy China 2030 and the reform path of excise tax on Tobacco. Int Tax Chin. 2022;111(09):57-64. doi:10.19376/j.cnki.cn10-1142/f.2022.09.008 (In Chinese)
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
